AVR 8-K
Anteris Technologies Global Corp. (AVR)
8-K
2026-08-03
For: 2026-08-03
View Original
Added on
August 03, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 3, 2026
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: +61 7 3152 3200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01. |
Regulation FD Disclosure
|
On August 3, 2026, Anteris Technologies Global Corp. (the “Company”) submitted the materials attached as Exhibit 99.1 to the Australian Securities
Exchange.
The information contained in this Current Report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed to be
filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically
references this Current Report on Form 8-K.
| Item 9.01. |
Financial Statements and Exhibits.
|
(d) Exhibits.
The following exhibits are filed with this Current Report on Form 8-K:
|
Exhibit
No.
|
Description
|
|
|
ASX Announcement – Court Orders Granted
|
||
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
Anteris Technologies Global Corp.
|
||
|
Date: August 3, 2026
|
||
|
By:
|
/s/ Wayne Paterson
|
|
|
Name:
|
Wayne Paterson
|
|
|
Title:
|
Vice Chairman and Chief Executive Officer
|
|
Exhibit 99.1
Court Orders Granted
MINNEAPOLIS, United States and BRISBANE, Australia 3 August 2026: Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) advises that, further to its ASX announcement on 31 July 2026, Anteris’ application to the Federal Court of Australia to rectify an inadvertent administrative oversight relating to the late
lodgement of a cleansing notice under the Corporations Act 2001 (Cth) was heard earlier today and the Court has granted the relief sought.
A copy of the orders that were granted by the Federal Court of Australia is annexed to this announcement.
Anteris has requested that the trading halt in its securities be lifted by the ASX with effect from market open, 4 August 2026.
ENDS
Authorisation and Additional information
This announcement was authorised for release on the ASX by the Chief Financial Officer.
For more information:
|
Global Investor Relations
|
Investor Relations (US)
|
|
Debbie Ormsby
|
Malini Chatterjee, Ph.D.
|
|
Anteris Technologies Global Corp.
|
Blueprint Life Science Group
|
|
+61 1300 550 310 | +61 7 3152 3200
|
+1 917 330 4269
|
|
Website
|
www.anteristech.com
|
|
X
|
@AnterisTech
|
|
LinkedIn
|
https://www.linkedin.com/company/anteristech
|
|
860 Blue Gentian Road,
Suite 340
Eagan, MN, 55121 United States
T: +1 651 493 0606
|
Anteris
Technologies Global Corp.
|
Toowong Tower, Level 3,
Suite 302
9 Sherwood Road, Toowong
QLD 4066, Australia T: +61 1300 550 310
ARBN: 677 960 235
|
|
BRISBANE
| MINNEAPOLIS | GENEVA | MALAGA
|
||
 |
||
|
anteristech.com
|
Federal Court of Australia
District Registry: Victoria Registry
| Division: General | No: VID862/2026 |
ANTERIS TECHNOLOGIES GLOBAL CORP.
Plaintiff
ORDER
| JUDGE: | Justice Wheatley |
| DATE OF ORDER: | 3 August 2026 |
| WHERE MADE: | Brisbane |
THE COURT ORDERS THAT:
|
1.
|
Pursuant to s 1322(4)(d) of the Corporations Act 2001 (Cth)
(the Act), in respect of the 44,068 CHESS Depositary Interests in the Plaintiff that were issued on 10 July 2026 (Impacted CDIs), the period of 5 business days referred to in s 708A(6)(a) of the Act be extended to 31 July 2026.
|
|
2.
|
Pursuant to s 1322(4) of the Act, it is declared that a notice under s 708A(5)(e) of the Act given to the Australian Securities
Exchange Limited (ASX) in respect of the Impacted CDIs by the date provided for in order 1 be deemed to take effect as if it had been given to the ASX on 10 July
2026.
|
|
3.
|
Pursuant to s 1322(4)(a) of the Act, it is declared that any offer for sale or sale of any Impacted CDIs during the period after
their issuance on 10 July 2026 to the date of this order is not invalid by reason of:
|
|
(a)
|
any failure of a notice under s 708A(5)(e) of the Act to exempt the sellers from the obligation of disclosure under the Act; and
|
|
(b)
|
the sellers’ consequent failure to comply with s 707(3) or s 727(1) of the Act.
|
|
4.
|
Pursuant to s 1322(4)(c) of the Act, any person to whom any of the Impacted CDIs were issued, or have been sold, and who have in
turn on-sold any of those Impacted CDIs up until the date of this order, is relieved in whole from any civil liability in respect of:
|
Prepared in the Victoria Registry, Federal Court of Australia
Owen Dixon Commonwealth Law Courts Building, Level 7, 305 William Street, Melbourne, Telephone 1300 720 980
- 2 -
|
(a)
|
any failure of a notice under s 708A(5)(e) of the Act to exempt the sellers from the obligation of disclosure under the Act; or
|
|
(b)
|
the sellers’ failure to comply with s 707(3) or s 727(1) of the Act.
|
|
5.
|
The Plaintiff, as soon as reasonably practicable, is to serve a sealed copy of these orders on:
|
|
(a)
|
the Australian Securities and Investments Commission (ASIC);
|
|
(b)
|
the ASX; and
|
|
(c)
|
each person to whom Impacted CDIs were issued.
|
|
6.
|
As soon as reasonably practicable, the Plaintiff is to publish an announcement to the ASX in which a copy of these orders made is included and place
a copy of these orders on its own website to remain there for at least 28 days.
|
|
7.
|
For a period of 28 days from the date of publication of a copy of these orders on the ASX market announcements platform, the ASIC or
any person who claims to have suffered substantial injustice or is likely to suffer substantial injustice by the making of any or all of these orders has liberty to apply to vary or to discharge the orders within that period.
|
|
8.
|
There be no order as to costs.
|
Date orders authenticated: 3 August 2026
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Prepared in the Victoria Registry, Federal Court of Australia
Owen Dixon Commonwealth Law Courts Building, Level 7, 305 William Street, Melbourne, Telephone 1300 720 980